Gift Opening
$200 Off MarketBeat All Access
Thanks for being one of our best subscribers! You are eligible for a limited-time discount.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
Claim Your Discount
×
Free Trial

Equitrans Midstream Co. (NYSE:ETRN) Shares Sold by Los Angeles Capital Management LLC

Los Angeles Capital Management LLC cut its stake in Equitrans Midstream Co. (NYSE:ETRN - Free Report) by 34.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 268,066 shares of the company's stock after selling 139,768 shares during the period. Los Angeles Capital Management LLC owned 0.06% of Equitrans Midstream worth $2,729,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. Harvest Fund Management Co. Ltd acquired a new stake in shares of Equitrans Midstream during the 4th quarter worth approximately $39,000. AlphaMark Advisors LLC lifted its stake in shares of Equitrans Midstream by 66.2% in the 3rd quarter. AlphaMark Advisors LLC now owns 5,650 shares of the company's stock valued at $53,000 after purchasing an additional 2,250 shares during the period. DekaBank Deutsche Girozentrale acquired a new stake in shares of Equitrans Midstream during the third quarter worth $55,000. Operose Advisors LLC bought a new stake in Equitrans Midstream in the third quarter valued at about $56,000. Finally, Hexagon Capital Partners LLC boosted its holdings in Equitrans Midstream by 185.8% during the fourth quarter. Hexagon Capital Partners LLC now owns 5,716 shares of the company's stock worth $58,000 after buying an additional 3,716 shares during the last quarter. Institutional investors and hedge funds own 87.35% of the company's stock.

Equitrans Midstream Stock Down 0.7 %

Shares of Equitrans Midstream stock traded down $0.10 during trading hours on Tuesday, reaching $13.62. The company's stock had a trading volume of 7,370,801 shares, compared to its average volume of 6,294,729. The company has a debt-to-equity ratio of 4.88, a quick ratio of 0.63 and a current ratio of 0.63. Equitrans Midstream Co. has a one year low of $5.06 and a one year high of $14.21. The company has a market capitalization of $5.91 billion, a P/E ratio of 15.12, a P/E/G ratio of 1.85 and a beta of 1.93. The stock's fifty day simple moving average is $12.06 and its two-hundred day simple moving average is $10.63.


Equitrans Midstream (NYSE:ETRN - Get Free Report) last released its earnings results on Tuesday, April 30th. The company reported $0.23 earnings per share for the quarter, beating analysts' consensus estimates of $0.20 by $0.03. The firm had revenue of $364.27 million during the quarter, compared to the consensus estimate of $345.79 million. Equitrans Midstream had a net margin of 31.69% and a return on equity of 30.21%. The company's revenue was down 3.2% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.22 EPS. On average, research analysts forecast that Equitrans Midstream Co. will post 0.86 earnings per share for the current year.

Equitrans Midstream Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Tuesday, May 7th will be paid a dividend of $0.15 per share. The ex-dividend date is Monday, May 6th. This represents a $0.60 annualized dividend and a yield of 4.41%. Equitrans Midstream's dividend payout ratio is currently 66.67%.

Wall Street Analysts Forecast Growth

A number of brokerages have recently weighed in on ETRN. Morgan Stanley lowered their target price on Equitrans Midstream from $13.00 to $12.00 and set an "overweight" rating on the stock in a research note on Thursday, February 22nd. Wells Fargo & Company upped their target price on Equitrans Midstream from $12.00 to $13.00 and gave the company an "equal weight" rating in a research report on Thursday, May 2nd. Royal Bank of Canada reaffirmed an "outperform" rating and issued a $13.00 price target on shares of Equitrans Midstream in a research note on Thursday, March 7th. Barclays increased their price objective on shares of Equitrans Midstream from $6.00 to $11.00 and gave the stock an "equal weight" rating in a research note on Monday, February 26th. Finally, US Capital Advisors lowered shares of Equitrans Midstream from an "overweight" rating to a "hold" rating in a report on Monday, April 29th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Hold" and an average price target of $11.19.

Get Our Latest Analysis on ETRN

Equitrans Midstream Company Profile

(Free Report)

Equitrans Midstream Corporation owns, operates, acquires, and develops midstream assets in the Appalachian Basin. The company operates through Gathering, Transmission, and Water segments. It operates dry gas gathering systems of high-pressure gathering lines and FERC-regulated interstate pipelines and storage systems.

Featured Stories

Institutional Ownership by Quarter for Equitrans Midstream (NYSE:ETRN)

→ Kiss of death from Joe Biden (From Porter & Company) (Ad)

Should you invest $1,000 in Equitrans Midstream right now?

Before you consider Equitrans Midstream, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Equitrans Midstream wasn't on the list.

While Equitrans Midstream currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Featured Articles and Offers

Biotech Boom: Stocks Skyrocketing & What's Next

Biotech Boom: Stocks Skyrocketing & What's Next

Dive into biotech's latest trends with Dylan Jovine: weight loss breakthroughs, smart chemo innovations, and expert stock evaluation tips.

Search Headlines: